Anatomic Stage III Breast Cancer AJCC v8: Clinical Trials

159 trials for Anatomic Stage III Breast Cancer AJCC v8, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

43 recruiting, 41 completed, 32 active not recruiting, 19 terminated. 49 Not applicable, 47 Phase 2, 32 Phase 1, 8 Phase 3, 7 Early Phase 1.

By phase and status

PhaseTrialsStatus
Not applicable49Completed 15, Recruiting 11, Active not recruiting 9, Terminated 7, Withdrawn 4, Not yet recruiting 2, Unknown 1
Phase 247Recruiting 17, Active not recruiting 10, Completed 7, Terminated 6, Withdrawn 4, Not yet recruiting 3
Phase 132Completed 11, Active not recruiting 7, Recruiting 7, Withdrawn 3, Suspended 2, Not yet recruiting 1, Terminated 1
Phase 38Active not recruiting 5, Recruiting 2, Completed 1
Early Phase 17Completed 3, Recruiting 2, Withdrawn 2
Phase 42Not yet recruiting 1, Terminated 1

Follow Anatomic Stage III Breast Cancer AJCC v8: new trials by email Literature Review of Anatomic Stage III Breast Cancer AJCC v8 trials Research Report on Anatomic Stage III Breast Cancer AJCC v8

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Biology Guided Therapy Recommendations for Treatment Determination of Hormone Receptor-Positive Advanced, Unresectable or Metastatic Breast Cancer, ENDORSE Trial
Biopsy Procedure, Biospecimen Collection, Bone Scan - Advanced Hormone Receptor-Positive Breast Carcinoma, Anatomic Stage III Breast Cancer AJCC v8
Phase 1Not yet recruitingCity of Hope Medical Center202026-12-192026-05-15
Minoxidil With or Without Low-Level Red-Light Therapy for Improving Chemotherapy-Induced Alopecia in Breast Cancer Patients
Electronic Health Record Review, Minoxidil, Revian RED LED-light cap - Anatomic Stage I Breast Cancer AJCC v8, Anatomic Stage II Breast Cancer AJCC v8
Phase 2Not yet recruitingOhio State University Comprehensive Cancer Center502026-11-152026-09-02
A Vaccine (STEMVAC) for Improving Survival in Patients With Triple-Negative Breast Cancer and Moderate or Extensive Residual Cancer Burden
CD105/Yb-1/SOX2/CDH3/MDM2-polyepitope Plasmid DNA Vaccine, Recombinant Granulocyte-Macrophage Colony-Stimulating Factor, Biospecimen Collection - Anatomic Stage I Breast Cancer AJCC v8, Anatomic Stage II Breast Cancer AJCC v8
Phase 2Not yet recruitingUniversity of Washington602026-11-012026-10-16
Web-based Lifestyle Program, mHealth and EMA Intervention, to Improve Weight Loss in Rural Stage I-III Postmenopausal Breast and Endometrial Cancer Survivors, HERO-C Trial
Aerobic Exercise, Biospecimen Collection, Dietary Intervention - Anatomic Stage I Breast Cancer AJCC v8, Anatomic Stage II Breast Cancer AJCC v8
Not applicableNot yet recruitingOhio State University Comprehensive Cancer Center902026-10-102026-07-23
Testing the Safety of the Combination of Anti-Cancer Drugs CX-5461 (Pidnarulex) and Trastuzumab Deruxtecan (T-DXd) for Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Solid Tumors and Breast Cancer
Biopsy Procedure, Biospecimen Collection, Echocardiography Test - Anatomic Stage III Breast Cancer AJCC v8, Anatomic Stage IV Breast Cancer AJCC v8
Phase 1RecruitingNational Cancer Institute (NCI)362026-10-062026-10-16
Personalized Exercise Program for Survivors of Breast Cancer, STEPS-BC Trial
Exercise Intervention, Educational Intervention, Supportive Care - Anatomic Stage I Breast Cancer AJCC v8, Anatomic Stage II Breast Cancer AJCC v8
Not applicableRecruitingWake Forest University Health Sciences1202026-10-022026-10-06
US/PA/E Imaging for Early Identification of Tumor Response in Patients With Stage II-III Triple Negative Breast Cancer Receiving Neoadjuvant Immunotherapy and Chemotherapy
Elastography, Magnetic Resonance Imaging, Photoacoustic Imaging - Anatomic Stage II Breast Cancer AJCC v8, Anatomic Stage III Breast Cancer AJCC v8
Phase 2Not yet recruitingEmory University322026-10-012026-10-07
A Blended e-Health Intervention to Improve Fear of Progression in Women With Gynecologic or Breast Cancer
Best Practice, Interview, Supportive Care - Anatomic Stage I Breast Cancer AJCC v8, Anatomic Stage II Breast Cancer AJCC v8
Not applicableRecruitingCity of Hope Medical Center1262026-09-092026-10-16
Transcranial Direct Current Stimulation to Improve Gait for Breast Cancer Survivor's Who Received Taxene and/or Platinum Chemotherapy
Sham Intervention, Survey Administration, Transcranial Direct Current Stimulation - Anatomic Stage I Breast Cancer AJCC v8, Anatomic Stage II Breast Cancer AJCC v8
Not applicableNot yet recruitingUniversity of Michigan Rogel Cancer Center602026-09-012026-10-08
Semaglutide and Structured Lifestyle Support to Improve Heart and Blood Vessel Health in Postmenopausal Obese Breast Cancer Survivors Taking Aromatase Inhibitors
Biospecimen Collection, Dual X-ray Absorptiometry, Functional Assessment - Anatomic Stage I Breast Cancer AJCC v8, Anatomic Stage II Breast Cancer AJCC v8
Phase 4Not yet recruitingMayo Clinic502026-09-012026-08-17
A Navigation Program to Improve Survivorship Support Service Participation Among Non-metastatic Breast Cancer Survivors
Best Practice, Patient Navigation, Referral - Anatomic Stage 0 Breast Cancer AJCC v8, Anatomic Stage I Breast Cancer AJCC v8
Not applicableRecruitingOhio State University Comprehensive Cancer Center3302026-09-012026-08-14
Virtual Mental Health Intervention to Address Fear of Progression for Women With High Risk or Stage III-IV Gynecologic or Breast Cancer
Behavioral Intervention, Educational Intervention, Internet-Based Intervention - Anatomic Stage III Breast Cancer AJCC v8, Anatomic Stage IV Breast Cancer AJCC v8
Not applicableWithdrawnCity of Hope Medical Center2026-07-162026-02-04
Online Nutrition Education to Decrease the Side Effects of Chemotherapy in Patients With Breast Cancer
Best Practice, Internet-Based Intervention, Questionnaire Administration - Anatomic Stage I Breast Cancer AJCC v8, Anatomic Stage II Breast Cancer AJCC v8
Not applicableRecruitingFred Hutchinson Cancer Center502026-07-152026-08-06
Evaluation of Alternative Site Goserelin Acetate Injection for Ovarian Function Suppression (OFS) in Local and Locally Advanced Premenopausal Hormone Receptor Positive Breast Cancer Patients
Biospecimen Collection, Goserelin Acetate, Questionnaire Administration - Anatomic Stage I Breast Cancer AJCC v8, Anatomic Stage II Breast Cancer AJCC v8
Phase 2RecruitingMayo Clinic982026-05-222026-10-01
Imlunestrant and Abemaciclib for the Treatment of Estrogen Receptor Positive Breast Cancer in Patients With Minimal Residual Disease, MIRI Trial
Abemaciclib, Biospecimen Collection, Imlunestrant - Anatomic Stage I Breast Cancer AJCC v8, Anatomic Stage II Breast Cancer AJCC v8
Phase 2RecruitingJonsson Comprehensive Cancer Center422026-05-182026-08-20
Circulating Tumor DNA Based Minimal Residual Disease Detection for Patients With Early-Stage Breast Cancer
Biospecimen Collection, Electronic Health Record Review, Survey Administration - Anatomic Stage I Breast Cancer AJCC v8, Anatomic Stage II Breast Cancer AJCC v8
Not applicableWithdrawnCity of Hope Medical Center2026-05-122026-06-25
A Dietary Supplement (Resistant Potato Starch) for Reducing Musculoskeletal Symptoms in Individuals Planning to Receive Aromatase Inhibitor Therapy, AIMSS-RPS Trial
Starch, Potato - Anatomic Stage 0 Breast Cancer AJCC v8, Anatomic Stage I Breast Cancer AJCC v8
Phase 2RecruitingUniversity of Michigan Rogel Cancer Center202026-04-222026-04-24
Tamoxifen and Pegylated Liposomal Doxorubicin for the Treatment of Patients With Metastatic or Inoperable, Locally Advanced Triple Negative Breast Cancer
Biopsy, Biospecimen Collection, Computed Tomography - Anatomic Stage III Breast Cancer AJCC v8, Anatomic Stage IV Breast Cancer AJCC v8
Phase 2RecruitingRoswell Park Cancer Institute302026-03-032026-04-24
Leuprolide and Goserelin for Ovarian Function Suppression in Pre- or Peri-menopausal Women With Breast Cancer, OFS Trial
Biospecimen Collection, Electronic Health Record Review, Goserelin - Anatomic Stage I Breast Cancer AJCC v8, Anatomic Stage II Breast Cancer AJCC v8
Phase 2RecruitingUniversity of Michigan Rogel Cancer Center752026-01-222026-06-23
Personalized Vaccine Immunotherapy in Combination With Checkpoint Inhibitor for Treatment of Triple Negative Breast Cancer
Ipilimumab, Pembrolizumab, Vaccine Therapy - Anatomic Stage I Breast Cancer AJCC v8, Anatomic Stage IA Breast Cancer AJCC v8
Phase 1RecruitingEmory University182025-12-022026-01-26

Showing 20 of 159. Sign in to see all of them.

Narrower conditions

Triple Negative Breast Neoplasms (37)  ·  Breast Neoplasms (34)  ·  Ovarian Neoplasms (17)  ·  Breast Carcinoma In Situ (16)  ·  Neoplasm Metastasis (12)  ·  Prostatic Neoplasms (11)  ·  Lung Neoplasms (10)  ·  Colorectal Neoplasms (9)  ·  Endometrial Neoplasms (8)  ·  Pancreatic Neoplasms (6)  ·  Carcinoma, Non-Small-Cell Lung (5)  ·  Fallopian Tube Neoplasms (5)  ·  Uterine Cervical Neoplasms (5)  ·  Carcinoma, Intraductal, Noninfiltrating (4)  ·  Carcinoma, Renal Cell (4)

Broader conditions

Neoplasms (94)  ·  Neoplasms by Site (91)  ·  Breast Diseases (76)  ·  Skin Diseases (76)  ·  Skin and Connective Tissue Diseases (76)  ·  Breast Neoplasms (42)  ·  Neoplasms by Histologic Type (33)  ·  Neoplasms, Glandular and Epithelial (26)  ·  Urogenital Diseases (26)  ·  Carcinoma (25)  ·  Genital Diseases (25)  ·  Urogenital Neoplasms (24)  ·  Female Urogenital Diseases (22)  ·  Female Urogenital Diseases and Pregnancy Complications (22)  ·  Genital Diseases, Female (21)

Interventions

Specimen Handling (48)  ·  Magnetic Resonance Spectroscopy (28)  ·  Biopsy (27)  ·  Practice Guidelines as Topic (16)  ·  Taxes (16)  ·  Standard of Care (15)  ·  Paclitaxel (13)  ·  Early Intervention, Educational (10)  ·  Letrozole (9)  ·  Educational Status (8)  ·  Methods (8)  ·  pembrolizumab (8)  ·  Carboplatin (7)  ·  Fulvestrant (7)  ·  Interviews as Topic (7)

Sponsors

Mayo Clinic (28)  ·  M.D. Anderson Cancer Center (23)  ·  National Cancer Institute (NCI) (20)  ·  Ohio State University Comprehensive Cancer Center (17)  ·  City of Hope Medical Center (9)  ·  Fred Hutchinson Cancer Center (8)  ·  Emory University (7)  ·  University of Washington (7)  ·  Jonsson Comprehensive Cancer Center (5)  ·  University of Michigan Rogel Cancer Center (4)  ·  Alliance for Clinical Trials in Oncology (3)  ·  OHSU Knight Cancer Institute (3)  ·  Roswell Park Cancer Institute (3)  ·  Thomas Jefferson University (3)  ·  University of California, San Francisco (3)

Countries

United States (149)  ·  Puerto Rico (6)  ·  Canada (3)  ·  Chile (1)  ·  Colombia (1)  ·  Mexico (1)  ·  Peru (1)  ·  South Africa (1)  ·  Uganda (1)

Top investigators

Heather Greenlee (4)  ·  Meghan Karuturi (3)  ·  Norah L Henry (3)  ·  Anne Reb (2)  ·  Brittany L Dulmage, MD (2)  ·  Matthew P. Goetz, M.D. (2)  ·  Meghan Karuturi, MD (2)  ·  Roisin M Connolly (2)  ·  Saranya Chumsri (2)  ·  Saranya Chumsri, MD (2)  ·  Senthilkumar Damodaran (2)  ·  Timiya Nolan, PhD (2)  ·  A P Chen (1)  ·  Abenaa M Brewster (1)  ·  Alison M Schram (1)

Results publications

PMID 33084020, PMID 33142018, PMID 34357781, PMID 34461975, PMID 34636255, PMID 34741653, PMID 35727609, PMID 35788100, PMID 36336249, PMID 36351402, PMID 36435952, PMID 36609349, PMID 36658425, PMID 37823909, PMID 37828596, PMID 38828938, PMID 39325778, PMID 39395534, PMID 39865083, PMID 40073831, PMID 40658949, PMID 40939237, PMID 40966714, PMID 41047708, PMID 41271741, PMID 41835341, PMID 42077327, PMID 42804742, PMID 42847673

NIH funding

P30CA033572 (10), P30CA138292 (6), UM1CA186709 (5), P30CA014089 (3), P30CA015704 (3), U10CA180820 (3), U10CA180821 (3), UM1CA186689 (3), UM1CA186691 (3), P30CA012197 (2), P30CA015083 (2), P30CA016042 (2), P30CA016672 (2), P50CA116201 (2), R21CA293326 (2)